Creavo Revenue and Competitors
Estimated Revenue & Valuation
- Creavo's estimated annual revenue is currently $1.3M per year.
- Creavo's estimated revenue per employee is $251,000
Employee Data
- Creavo has 5 Employees.
- Creavo grew their employee count by -17% last year.
Creavo's People
Name | Title | Email/Phone |
---|---|---|
1 | Production Controler | Reveal Email/Phone |
2 | Lead Research Physicist | Reveal Email/Phone |
Creavo Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is Creavo?
Creavo Medical Technologies Ltd is a UK-based, privately held medical technology company that is developing innovative diagnostic techniques for use in acute medical settings. The company was formed in 2014 by a group of clinical, research and business experts to bring to market technology developed by Professor Ben Varcoe, Chair of Quantum Information Science at Leeds University. It has facilities in Leeds and Coventry. Focused on improving front line patient care in acute medical settings, Creavo's first application of this pioneering technology is the Vitalscan – a device that meets an urgent clinical need in global cardiology to more accurately ‘rule out' heart-related problems at point of admission to emergency departments.
keywords:N/AN/A
Total Funding
5
Number of Employees
$1.3M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $0.5M | 5 | -17% | $76.7M |
#2 | $0.7M | 5 | N/A | N/A |
#3 | $0.3M | 5 | N/A | N/A |
#4 | $0.5M | 5 | N/A | N/A |
#5 | $0.5M | 5 | N/A | N/A |